Lymph node dissection of right hemicolectomy for colon cancer: range of dissection, controversial issues, and precision strategies
10.3760/cma.j.cn441530-20250320-00113
- VernacularTitle:右半结肠癌淋巴结清扫：范围界定及其争议焦点与精准清扫策略
- Author:
Kexuan LI
1
;
Yi XIAO
1
Author Information
1. 中国医学科学院 北京协和医学院 北京协和医院基本外科结直肠专业组，北京 100730
- Publication Type:Journal Article
- Keywords:
Colon Neoplasms, right colon;
Surgery;
Lymphadenectomy
- From:
Chinese Journal of Gastrointestinal Surgery
2025;28(9):978-982
- CountryChina
- Language:Chinese
-
Abstract:
A minimum of 12 lymph nodes examined is a requirement for the pathological specimens of radical colon cancer surgery according to the NCCN guidelines. However, the increase in the number of lymph nodes examined by expanding the range of lymph node dissection is not the fundamental factor. Addressing whether the range of lymph node dissection brings benefits requires evidence from researches. In recent years, high-level evidence brought by the RELARC trial has defined the indications for central lymph node dissection in the right hemicolectomy. Clinical research on indications for infrapyloric and gastroepiploic lymph nodes and non-regional/non-feeding vessel lymph node dissection has also been carried out. This article provides strategic references in the era of precision medicine by clarifying the research evidence about controversial issues related to lymph node dissection in right hemicolectomy.
